Sophion Bioscience A/S Segment Contributing Large Share To Global Automated Patch Clamp System Market
Market Overview:
Automated patch clamp technique enables rapid throughput screening and characterization of ion channel. It combines traditional patch clamp techniques with fully automated fluidics and precision robotics to record ion channel activities. It allows researchers to significantly speed up drug discovery and development by screening large compound libraries against ion channel targets.
Market key trends:
One of the major trends in the automated patch clamp system market is increasing R&D investment by pharmaceutical companies for drug discovery. Pharmaceutical companies are investing heavily on the development of novel drugs for the treatment of various diseases such as cancer and neurological disorders. As automated patch clamp systems allow high throughput screening of drug compounds against ion channel targets, their adoption is increasing significantly among pharmaceutical companies. For instance, in 2019, global R&D spending in the pharmaceutical industry increased to US$ 179 billion. This trend is expected to drive the growth of the automated patch clamp system market over the forecast period.
Segment Analysis
The automated patch clamp system market is classified into three major segments based on product type: multi-well patch clamp systems, single-well patch clamp systems, and high throughput patch clamp systems. The multi-well patch clamp systems segment accounts for the largest share of the global market owing to its ability to efficiently screen multiple ion channel targets simultaneously. These systems allow researchers to perform thousands of experiments per day, fueling their demand.
The global Automated Patch Clamp System Market Size is estimated to be valued at US$ 412.01 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Key Takeaways
The global automated patch clamp system market is expected to witness high growth, exhibiting a CAGR of 6.9% over the forecast period from 2023-2030, due to increasing R&D investments in pharmaceutical and biotechnology companies. Regionally, North America dominates the global market and is expected to maintain its position over the forecast period. This is attributed to the presence of major players in countries like the US.
The Asia Pacific region is anticipated to witness the highest growth rate during the forecast period owing to rising government funding for life science research and growing pharmaceutical industry in emerging economies such as China and India.
Key players operating in the automated patch clamp system market are Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH. These companies are focusing on new product launches and collaborative partnerships to strengthen their market position. For instance, in June 2023, Molecular Devices launched the PatchXpress 7000A Plus automated patch clamp system designed to screen hundreds of compounds efficiently.
Comments
Post a Comment